Investigating the effect of telmisartan on acrylamide-induced neurotoxicity through in vitro and in vivo methods
محل انتشار: مجله علوم پایه پزشکی ایران، دوره: 26، شماره: 9
سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 141
فایل این مقاله در 6 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJBMS-26-9_005
تاریخ نمایه سازی: 5 شهریور 1402
چکیده مقاله:
Objective(s): Acrylamide (ACR) is an environmental contaminant and neurotoxin. Telmisartan is an AT۱ blocker that has neuroprotective properties basically through its anti-oxidant effect. The effect of telmisartan on ACR-induced neurotoxicity was investigated in this study. Materials and Methods: Male Wistar rats were randomly assigned to eight groups (n=۶): ۱:Control (normal saline), ۲:ACR (۵۰ mg/kg, ۱۱ days, IP), ۳:ACR+vitamin E (۲۰۰ mg/kg, every other day, ۱۱ days), ۴-۶:ACR+telmisartan (۰.۶, ۱.۲۵, and ۲.۵ mg/kg, ۱۱ days, IP), ۷:ACR+telmisartan (۰.۶ mg/kg, days ۳–۱۱), ۸:Telmisartan (۲.۵ mg/kg, ۱۱ days). The behavioral test and blood pressure were assessed after ۱۱ days. Then, the levels of MDA and GSH in brain tissue were measured. The MTT assay was used to evaluate the effect of telmisartan on ACR-induced cytotoxicity.Results: Exposing PC۱۲ cells to ACR decreased cell viability versus the control group. Pretreating PC۱۲ cells with telmisartan (۰.۰۱۲۵, ۰.۰۲۵ µM) enhanced cell viability compared with the ACR group. Compared with control samples, ACR significantly caused motor impairment, elevated MDA, and reduced GSH levels. Locomotor abnormalities were significantly ameliorated by telmisartan (۰.۶, ۱.۲۵ mg/kg, ۱۱ days) and vitamin E versus the ACR group. Receiving telmisartan (۰.۶, ۱.۲۵, and ۲.۵ mg/kg) and vitamin E along with ACR decreased MDA levels and enhanced GSH content compared with the ACR group. There was no significant difference in animal blood pressure between the groups.Conclusion: Oxidative stress has a chief role in the neurotoxicity of ACR. Telmisartan (in doses that do not affect blood pressure) ameliorated ACR-induced toxicity by inhibiting oxidative stress.
کلیدواژه ها:
نویسندگان
Zahra Yazadanpanah
Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
Mahboobeh Ghasemzadeh Rahbardar
Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
Bibi Marjan Razavi
Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
Hossein Hosseinzadeh
Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :